Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Is the Forecasted Market Size of the Medicated Skincare Market by 2029?
The medicated skincare market size has grown strongly in recent years. It will grow from $37.80 billion in 2024 to $40.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing disposable income, rising adoption of skincare routines among men, a rise in urban pollution impacting skin health, an increasing geriatric population with skin-related issues, and rising demand for multifunctional medicated skincare products.
The medicated skincare market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the growing popularity of teledermatology consultations, increasing innovation in active pharmaceutical ingredients, rising consumer preference for clean and clinical skincare, expanding e-commerce penetration in skincare distribution, and increasing focus on preventive dermatology solutions. Major trends in the forecast period include advancement in skin microbiome-targeted therapies, development of AI-driven skin analysis tools, innovation in sustainable and eco-friendly formulations, advancement in personalized dermatological treatments, and development of prescription-strength skincare in retail channels.
Get your free report sample today:
What Are the Major Growth Drivers for the Medicated Skincare Market?
The rising prevalence of skin disorders is expected to propel the growth of the medicated skincare market going forward. Skin disorders refer to medical conditions that affect the skin’s appearance, texture, or function, causing issues such as rashes, inflammation, infections, or chronic diseases. The rising prevalence of skin disorders can be attributed to increasing levels of pollution in urban areas, as harmful pollutants penetrate the skin’s protective barrier, leading to inflammation, accelerated aging, and a higher risk of conditions such as eczema, acne, and dermatitis. Medicated skincare is useful for treating skin disorders as it contains active ingredients that address underlying issues such as inflammation, irritation, or microbial imbalance in the skin. For instance, in May 2023, according to the City of Hope, a US-based national cancer institute, melanoma currently accounts for 5.5% of all annual cancer diagnoses, with approximately 97,000 cases each year. Additionally, by 2030, this figure is projected to rise to 7.1%, totaling around 151,000 cases annually. Therefore, the rising prevalence of skin disorders is driving the growth of the medicated skincare market.
Which Key Segments Are Included in the Medicated Skincare Market Analysis?
The medicated skincare market covered in this report is segmented –
1) By Product: Pharmaceutical Grade Skincare, Prescription (Rx) Skincare
2) By Skin Condition: Acne, Psoriasis, Eczema, Rosacea, Other Skin Conditions
3) By Ingredient: Anti-Inflammatories, Antibacterials, Antifungals, Antioxidants, Moisturizers, Synthetic Ingredients, Natural Or Organic Ingredients, Chemical-Based Ingredients
4) By Distribution Channel: Dermatology Clinics, Online Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By Application: Creams, Lotions, Ointments, Gels, Serums
Subsegments:
1) By Pharmaceutical Grade Skincare: Anti-Acne Treatments, Anti-Aging Products, Skin Brightening Agents, Moisturizers With Active Ingredients, Sunscreens With Medicinal Properties, Post-Procedure Skincare
2) By Prescription (Rx) Skincare: Topical Antibiotics, Topical Corticosteroids, Antifungal Creams, Prescription Retinoids, Psoriasis Treatments, Rosacea Medications
What New Market Trends Are Emerging in the Medicated Skincare Market?
Major companies operating in the medicated skincare market are focusing on introducing innovative solutions, such as regenerative skincare cream to accelerate skin repair and reduce signs of aging, and enhance efficacy and promote healthier skin regeneration. Regenerative skincare cream refers to a medicated formulation enriched with active ingredients such as peptides and growth factors that help repair damaged skin, promote cell regeneration, and restore a healthier, more youthful appearance. For instance, in May 2025, SkinCeuticals, a US-based provider of skincare products, introduced Advanced RGN-6, a regenerative skincare cream inspired by laser regeneration science. This formulation is designed to visibly address six key signs of aging and skin tone irregularities, including redness, post-acne marks, dark spots, wrinkles, loss of firmness, and reduced smoothness. Advanced RGN-6 features a synergistic blend of six active ingredients, 10% Glyco-Repair, 1% Eperuline, 2% Niacinamide, 3% Acetyl Tetrapeptide-9, 0.2% Ectoin, and 0.2% Bioceramide 603, formulated to support both deep and superficial skin repair mechanisms. Clinical evaluations demonstrate that with consistent daily use, the cream significantly enhances skin texture and tone, delivering visible improvements within as little as one week. Furthermore, when applied post-laser treatment, it aids in accelerating recovery by minimizing downtime and improving skin hydration and smoothness.
Who Are the Leading Market Participants in the Medicated Skincare Market?
Major companies operating in the medicated skincare market are Obagi Medical Products Inc., Murad LLC, Laboratoire Bioderma, Revision Skincare Inc., Innovative Skincare Inc., PCA Skin Inc., Sesderma S.L., SkinMedica Inc., Neocutis Inc., Zota Health Care Limited, Alastin Skincare Inc., Dr. Wu Cosmetic Enterprise Co. Ltd., ZO Skin Health Inc., Skinbetter Science LLC, Alna Biotech Private Ltd., Epionce Inc., SkinCeuticals Inc., Canbro Healthcare, Scot Derma Private Ltd., Vibcare Pharma Private Ltd., TiZO Products Inc., Stelon Biotech Private Ltd., Hedge & Hedge Pharmaceutical.
Get the detailed medicated skincare market report today
Which Regions Are Driving the Highest Demand in the Medicated Skincare Market?
North America was the largest region in the medicated skincare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medicated skincare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment